Exenatide vs Navepegritide
Overview
Exenatide is primarily a weight management & metabolic peptide, while Navepegritide is used for bone & joint.
This page compares Exenatide and Navepegritide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Exenatide | Navepegritide | |
|---|---|---|
| Category | Weight Management & Metabolic | Bone & Joint |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) | — |
| Frequency | Twice daily (Byetta) or once weekly (Bydureon) | — |
| Reported benefits | Glycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL | — |
| Reported side effects | Nausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury | — |
Key differences
Primary use. Exenatide is categorised under Weight Management & Metabolic, while Navepegritide falls under Bone & Joint. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Exenatide: FDA-approved. Navepegritide: FDA-approved.
Dosing. Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)). Typical dosing for Navepegritide is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Exenatide and Navepegritide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Exenatide and Navepegritide?
- Exenatide is primarily a weight management & metabolic peptide, while Navepegritide is used for bone & joint. Exenatide is FDA-approved for one or more indications, whereas Navepegritide is FDA-approved for one or more indications.
- What is Exenatide used for?
- FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
- What is Navepegritide used for?
- PEGylated CNP analog for achondroplasia. FDA approved February 27, 2026.
- Can you take Exenatide and Navepegritide together?
- Some users combine peptides within a single protocol, but stacking Exenatide and Navepegritide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Exenatide or Navepegritide FDA-approved?
- Exenatide is FDA-approved for one or more indications. Navepegritide is FDA-approved for one or more indications.
Read the full articles
- Exenatide — full monograph: mechanism, research, dosing & references
- Navepegritide — full monograph: mechanism, research, dosing & references